<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35868667</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-8853</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinics in geriatric medicine</Title><ISOAbbreviation>Clin Geriatr Med</ISOAbbreviation></Journal><ArticleTitle>Inflammaging at the Time of COVID-19.</ArticleTitle><Pagination><StartPage>473</StartPage><EndPage>481</EndPage><MedlinePgn>473-481</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cger.2022.03.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0749-0690(22)00003-9</ELocationID><Abstract><AbstractText>Severe coronavirus disease 2019 (COVID-19) is associated with overproduction of proinflammatory cytokines. The ensuing cytokine storm contributes to the development of severe pneumonia and, possibly, to long-term symptom persistence (long COVID). The chronic state of low-grade inflammation that accompanies aging (inflammaging) might predispose older adults to severe COVID-19. Inflammaging may also contribute to symptom persistence following acute COVID-19. Antiinflammatory drugs and immunomodulatory agents can achieve significant therapeutic gain during acute COVID-19. Lifestyle interventions (eg, physical activity, diet) may be proposed as strategies to counteract inflammation and mitigate long-term symptom persistence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zazzara</LastName><ForeName>Maria Beatrice</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellieni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy. Electronic address: riccardo.calvani@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho-Junior</LastName><ForeName>H&#xe9;lio Jose</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy; Department of Geriatrics and Orthopedics, Universit&#xe0; Cattolica del Sacro Cuore, L.go F. Vito 1, Rome 00168, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picca</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzetti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00168, Italy; Department of Geriatrics and Orthopedics, Universit&#xe0; Cattolica del Sacro Cuore, L.go F. Vito 1, Rome 00168, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Geriatr Med</MedlineTA><NlmUniqueID>8603766</NlmUniqueID><ISSNLinking>0749-0690</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Diet</Keyword><Keyword MajorTopicYN="N">Immunosenescence</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Physical activity</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35868667</ArticleId><ArticleId IdType="pmc">PMC8934712</ArticleId><ArticleId IdType="doi">10.1016/j.cger.2022.03.003</ArticleId><ArticleId IdType="pii">S0749-0690(22)00003-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/ Available at: Accessed February 15 2022.</Citation></Reference><Reference><Citation>Sun P., Qie S., Liu Z., et al. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. J&#xa0;Med Virol. 2020;92:612&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228255</ArticleId><ArticleId IdType="pubmed">32108351</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N&#xa0;Engl J Med. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Du R.H., Liang L.R., Yang C.Q., et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55:2000524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144257</ArticleId><ArticleId IdType="pubmed">32269088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., He W., Yu X., et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J&#xa0;Infect. 2020;80:639&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118526</ArticleId><ArticleId IdType="pubmed">32240670</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine storm. N&#xa0;Engl J Med. 2020;383:2255&#x2013;2273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8:e46&#x2013;e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Mazza A., Gervasoni A., et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771&#x2013;1778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Ot&#xed;n C., Blasco M.A., Partridge L., et al. The hallmarks of aging. Cell. 2013;153:1194&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3836174</ArticleId><ArticleId IdType="pubmed">23746838</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonaf&#xe8; M., Valensin S., et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G. Age and immunity: what is &#x201c;immunosenescence&#x201d;. Exp Gerontol. 2018;105:4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29111233</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.J., Lee J.K., Shin O.S. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw. 2019;19:e37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943173</ArticleId><ArticleId IdType="pubmed">31921467</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R., Lippi A., Setz C., et al. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime. Aging (Albany NY) 2020;12:18778&#x2013;18789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585069</ArticleId><ArticleId IdType="pubmed">32991323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Garagnani P., Parini P., et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J., D&#x2019;Adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667954</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Calvani R., Coelho-Junior H.J., et al. Cell death and inflammation: the role of mitochondria in health and disease. Cells. 2021;10:537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998762</ArticleId><ArticleId IdType="pubmed">33802550</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagi E., Candela M., Franceschi C., et al. The aging gut microbiota: new perspectives. Ageing Res Rev. 2011;10:428&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">21402177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragonnaud E., Biragyn A. Gut microbiota as the key controllers of &#x201c;healthy&#x201d; aging of elderly people. Immun Ageing. 2021;18:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784378</ArticleId><ArticleId IdType="pubmed">33397404</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio M., Guralnik J.M., Longo D.L., et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J&#xa0;Gerontol A Biol Sci Med Sci. 2006;61:575&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2645627</ArticleId><ArticleId IdType="pubmed">16799139</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal P., Stubbs B., Lucato P., et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27592340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Harris T.B., Guralnik J.M., et al. Serum IL-6 level and the development of disability in older persons. J&#xa0;Am Geriatr Soc. 1999;47:639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">10366160</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Salvioli S., Garagnani P., et al. Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front Immunol. 2017;8:982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5559470</ArticleId><ArticleId IdType="pubmed">28861086</ArticleId></ArticleIdList></Reference><Reference><Citation>Gensous N., Bacalini M.G., Pirazzini C., et al. The epigenetic landscape of age-related diseases: the geroscience perspective. Biogerontology. 2017;18:549&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514215</ArticleId><ArticleId IdType="pubmed">28352958</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L., Di Benedetto S. How immunosenescence and inflammaging may contribute to hyperinflammatory syndrome in COVID-19. Int J Mol Sci. 2021;22:12539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618618</ArticleId><ArticleId IdType="pubmed">34830421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., R&#xe9;nia L., et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojtabavi H., Saghazadeh A., Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020;31:44&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530350</ArticleId><ArticleId IdType="pubmed">32933891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaf&#xe8; M., Olivieri F., Cavallone L., et al. A&#xa0;gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol. 2001;31:2357&#x2013;2361.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A., Schurman S.H., Franceschi C., et al. A&#xa0;public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Bitna-Ha, Kim S.-W., et al. Post-acute COVID-19 syndrome in patients after 12&#xa0;months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Coronavirus disease (COVID-19): post COVID-19 condition. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition Available at: Accessed 15 February 2022.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines. 2021;9:497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., et al. Long covid - mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G., Yadav S., Kumar R. Post-intensive care syndrome: an overview. J&#xa0;Transl Intern Med. 2017;5:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson D., Jackson T., Sapey E., et al. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223244</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea S., Merchant R.M., Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180:817&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32:1613&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19. N&#xa0;Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain D.W., Cidlowski J.A. After 62 years of regulating immunity, dexamethasone meets COVID-19. Nat Rev Immunol. 2020;20:587&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416654</ArticleId><ArticleId IdType="pubmed">32778829</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F., Agoritsas T., MacDonald H., et al. A&#xa0;living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379.</Citation><ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Wang W., Hayek S.S., et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577201</ArticleId><ArticleId IdType="pubmed">33080002</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Therapeutics and COVID-19: living guidelines. https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.1 Available at. Accessed 15 February 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E., Poulakou G., Milionis H., et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021;27:1752&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516650</ArticleId><ArticleId IdType="pubmed">34480127</ArticleId></ArticleIdList></Reference><Reference><Citation>Huet T., Beaussier H., Voisin O., et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;2:e393&#x2013;e400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7259909</ArticleId><ArticleId IdType="pubmed">32835245</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M., Tiseo G., Giordano C., et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J&#xa0;Antimicrob Chemother. 2020;76:1078&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799007</ArticleId><ArticleId IdType="pubmed">33374002</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J., Fu M., Mei H., et al. Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis. Rev Med Virol. 2021 doi: 10.1002/rmv.2295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2295</ArticleId><ArticleId IdType="pmc">PMC8646369</ArticleId><ArticleId IdType="pubmed">34558756</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084355</ArticleId><ArticleId IdType="pubmed">33933206</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods J.A., Hutchinson N.T., Powers S.K., et al. The COVID-19 pandemic and physical activity. Sport Med Heal Sci. 2020;2:55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261095</ArticleId><ArticleId IdType="pubmed">34189484</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyh C., Kr&#xfc;ger K., Strasser B. Physical activity and diet shape the immune system during aging. Nutrients. 2020;12:622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146449</ArticleId><ArticleId IdType="pubmed">32121049</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R.J., Lowder T.W., Spielmann G., et al. Exercise and the aging immune system. Ageing Res Rev. 2012;11:404&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">22465452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tylutka A., Morawin B., Gramacki A., et al. Lifestyle exercise attenuates immunosenescence; flow cytometry analysis. BMC Geriatr. 2021;21:200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7986285</ArticleId><ArticleId IdType="pubmed">33752623</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller J., Chalaris A., Schmidt-Arras D., et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296109</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkie R., Ostrowski S.R., Jauffred S., et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003;17:884&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">12626436</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro A., Pini E., Scurti M., et al. Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project&#x2019;s conceptual framework and design. Mech Ageing Dev. 2014:136&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">24342354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervo M.M.C., Scott D., Seibel M.J., et al. Proinflammatory diet increases circulating inflammatory biomarkers and falls risk in community-dwelling older men. J&#xa0;Nutr. 2020;150:373&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">31665502</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawrzyniak-Gramacka E., Hertmanowska N., Tylutka A., et al. The association of anti-inflammatory diet ingredients and lifestyle exercise with inflammaging. Nutrients. 2021;13:3696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621229</ArticleId><ArticleId IdType="pubmed">34835952</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighatdoost F., Bellissimo N., Totosy De Zepetnek J.O., et al. Association of vegetarian diet with inflammatory biomarkers: a systematic review and meta-analysis of observational studies. Public Health Nutr. 2017;20:2713&#x2013;2721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10261540</ArticleId><ArticleId IdType="pubmed">28836492</ArticleId></ArticleIdList></Reference><Reference><Citation>Berendsen A.A.M., van de Rest O., Feskens E.J.M., et al. Changes in dietary intake and adherence to the NU-AGE diet following a one-year dietary intervention among European older adults&#x2014;results of the NU-AGE randomized trial. Nutrients. 2018;10:1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315357</ArticleId><ArticleId IdType="pubmed">30518044</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>